Applied Genetic Technologies (AGTC) Posts Q4 Loss of 48c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Applied Genetic Technologies (AGTC) Posts Q4 Loss of 48c/Share

AGTC Announces Financial Results for the Quarter and Fiscal Year Ended June 30, 2015

September 10, 2015 4:12 PM EDT

GAINESVILLE, Fla., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced financial results for the quarter and fiscal year ended June 30, 2015.

"This has been an exciting and transformative period for AGTC," said Sue Washer, President and CEO. "In addition to commencing enrollment in our clinical trial for XLRS, our recent collaboration with Biogen will enable us to expedite development of our lead programs as well as advance additional therapeutic... More